ArticleBMC musculoskeletal disorders2026
Translation, validation, and reliability of Örebro Musculoskeletal Screening Questionnaire in Nepali.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe prevalence of psychosocial risk factors and disability are increasing in Nepal calling for biopsychosocial tools for evaluation of musculoskeletal pain and prediction of risk factors. Örebro Musculoskeletal Screening Questionnaire (OMSQ) is a 21-item tool that is used to identify patients at risk of developing disability from nonspecific musculoskeletal pain conditions. The purpose of this study was to translate OMSQ, validate and test the reliability of the Nepali version of the OMSQ in both the urban and rural population.
methodsOMSQ was translated into Nepali according to Beaton and tested for validity and reliability in urban and rural clinics by adult persons with chronic non-specific musculoskeletal pain (n = 147). Internal consistency was calculated by Cronbach’s alpha and test–retest reliability was evaluated by intraclass correlation coefficient, ICC. Responsiveness using a ROC curve was used to estimate sensitivity and specificity to detect a change in OMSQ between the test and retest. Floor and ceiling effects of the OMSQ scores were analyzed. The experience with OMSQ was surveyed with closed- and open-ended questions. The narratives were assessed with categoric content analysis.
resultsMeaning and measurement properties of Nepali OMSQ were retained when translated into Nepali and found reliable (ICC > 0.75) and valid for use in both urban and rural settings in Nepal showing high internal consistency (Cronbach’s alpha urban pre-post; 0.790 and 0.768, rural pre-post; 0.827 and 0.783). ROC showed good responsiveness for urban and rural, area under curve (AUC) 0.751 and 0.760 respectively). Total scores were evenly distributed without floor or ceiling effects. In general, OMSQ was considered easy/moderate to understand/complete, though respondents in the rural sample needed more time to complete. Some of the participants had difficulties with long words and understanding of the Likert-scale.
conclusionOMSQ was successfully translated to Nepali and found to be a reliable and valid instrument for assessing psychosocial parameters associated with nonspecific musculoskeletal pain across diverse settings in Nepal.
trial registrationNot applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.